Use of .alpha.1A adrenoceptor agonists with .alpha.1B and .alpha.1D antagonism for the treatment of stress urinary incontinence
US6323231A · kind A · utility
4Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 2001 |
| Grant date | Nov 27, 2001 |
| Priority date | — |
| Expiry date | Feb 16, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The following disclosure relates to a method of treating incontinence with a compound having a specific .alpha..sub.1A adrenoceptor profile.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.